Gresham Richter
Concepts (508)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Vascular Malformations | 23 | 2025 | 102 | 8.040 |
Why?
| Arteriovenous Malformations | 18 | 2024 | 76 | 7.860 |
Why?
| Hemangioma | 14 | 2022 | 83 | 5.540 |
Why?
| Glottis | 9 | 2024 | 34 | 3.940 |
Why?
| Laryngomalacia | 10 | 2024 | 25 | 3.840 |
Why?
| Propranolol | 10 | 2020 | 79 | 3.140 |
Why?
| Lymphatic Abnormalities | 7 | 2020 | 22 | 3.110 |
Why?
| Infant | 52 | 2024 | 3628 | 2.480 |
Why?
| Child | 58 | 2025 | 6906 | 2.170 |
Why?
| Neck | 11 | 2022 | 99 | 2.160 |
Why?
| Child, Preschool | 45 | 2024 | 3942 | 1.950 |
Why?
| Sclerotherapy | 11 | 2023 | 46 | 1.950 |
Why?
| Lasers, Solid-State | 5 | 2020 | 32 | 1.880 |
Why?
| Humans | 121 | 2025 | 50503 | 1.870 |
Why?
| Laryngoscopy | 10 | 2020 | 59 | 1.780 |
Why?
| Ambulatory Surgical Procedures | 3 | 2024 | 52 | 1.770 |
Why?
| Laryngostenosis | 4 | 2020 | 11 | 1.760 |
Why?
| Deglutition Disorders | 5 | 2017 | 77 | 1.750 |
Why?
| Treatment Outcome | 35 | 2024 | 5283 | 1.650 |
Why?
| Laser Therapy | 6 | 2020 | 83 | 1.560 |
Why?
| Laryngoplasty | 2 | 2024 | 8 | 1.550 |
Why?
| Vascular Surgical Procedures | 5 | 2020 | 166 | 1.420 |
Why?
| Otolaryngology | 6 | 2025 | 61 | 1.380 |
Why?
| Male | 70 | 2024 | 25907 | 1.350 |
Why?
| Tonsillectomy | 4 | 2021 | 49 | 1.280 |
Why?
| Larynx | 7 | 2017 | 30 | 1.280 |
Why?
| Veins | 6 | 2023 | 73 | 1.270 |
Why?
| Female | 69 | 2024 | 27081 | 1.270 |
Why?
| Hemangioma, Capillary | 2 | 2020 | 12 | 1.240 |
Why?
| Retrospective Studies | 34 | 2024 | 6263 | 1.230 |
Why?
| Embolization, Therapeutic | 6 | 2023 | 88 | 1.210 |
Why?
| Head | 5 | 2022 | 70 | 1.080 |
Why?
| Skin | 5 | 2020 | 388 | 1.050 |
Why?
| Trachea | 5 | 2018 | 52 | 0.930 |
Why?
| Heart Bypass, Right | 1 | 2024 | 15 | 0.920 |
Why?
| Arteriovenous Fistula | 1 | 2024 | 30 | 0.910 |
Why?
| Pulmonary Veins | 1 | 2024 | 41 | 0.900 |
Why?
| Blood Proteins | 1 | 2024 | 84 | 0.900 |
Why?
| Adolescent | 29 | 2024 | 6443 | 0.890 |
Why?
| Facial Neoplasms | 2 | 2017 | 22 | 0.880 |
Why?
| Tongue | 4 | 2023 | 40 | 0.880 |
Why?
| Vocal Cord Paralysis | 2 | 2022 | 22 | 0.870 |
Why?
| Fontan Procedure | 1 | 2024 | 70 | 0.870 |
Why?
| Otorhinolaryngologic Diseases | 2 | 2014 | 11 | 0.860 |
Why?
| Head and Neck Neoplasms | 5 | 2015 | 287 | 0.850 |
Why?
| Cell Proliferation | 7 | 2023 | 985 | 0.850 |
Why?
| Collagen | 2 | 2019 | 204 | 0.840 |
Why?
| Pulmonary Artery | 1 | 2024 | 154 | 0.830 |
Why?
| Infant, Newborn | 20 | 2024 | 2749 | 0.820 |
Why?
| Proteome | 1 | 2024 | 169 | 0.810 |
Why?
| Face | 2 | 2020 | 58 | 0.810 |
Why?
| Health Information Systems | 1 | 2022 | 15 | 0.800 |
Why?
| Respiratory Aspiration | 2 | 2014 | 9 | 0.790 |
Why?
| Surgery, Computer-Assisted | 2 | 2020 | 55 | 0.790 |
Why?
| Adrenergic beta-Antagonists | 4 | 2020 | 108 | 0.780 |
Why?
| Nitric Oxide Synthase Type III | 2 | 2013 | 78 | 0.780 |
Why?
| Hyperpigmentation | 1 | 2021 | 9 | 0.770 |
Why?
| Proteomics | 1 | 2024 | 314 | 0.760 |
Why?
| Cricoid Cartilage | 2 | 2020 | 11 | 0.760 |
Why?
| Receptors, Progesterone | 1 | 2021 | 64 | 0.720 |
Why?
| Otorhinolaryngologic Surgical Procedures | 3 | 2014 | 34 | 0.720 |
Why?
| Graft Survival | 4 | 2011 | 159 | 0.710 |
Why?
| Ambulatory Care Facilities | 1 | 2021 | 120 | 0.710 |
Why?
| Intracranial Arteriovenous Malformations | 2 | 2019 | 30 | 0.700 |
Why?
| Dermatologic Surgical Procedures | 1 | 2020 | 34 | 0.700 |
Why?
| Dilatation | 2 | 2017 | 26 | 0.700 |
Why?
| Receptors, Estrogen | 1 | 2021 | 132 | 0.700 |
Why?
| Prospective Studies | 8 | 2022 | 2378 | 0.680 |
Why?
| Risk Assessment | 10 | 2018 | 1270 | 0.680 |
Why?
| Tracheostomy | 3 | 2022 | 71 | 0.660 |
Why?
| Elastin | 1 | 2019 | 22 | 0.650 |
Why?
| Vasodilator Agents | 2 | 2017 | 100 | 0.650 |
Why?
| Inpatients | 1 | 2021 | 193 | 0.640 |
Why?
| Gene Expression Profiling | 3 | 2020 | 1025 | 0.640 |
Why?
| Gastroesophageal Reflux | 2 | 2017 | 50 | 0.640 |
Why?
| Skin Transplantation | 3 | 2009 | 43 | 0.630 |
Why?
| Vascular Endothelial Growth Factor A | 3 | 2009 | 182 | 0.620 |
Why?
| Endothelial Cells | 4 | 2024 | 258 | 0.620 |
Why?
| Follow-Up Studies | 12 | 2018 | 2242 | 0.620 |
Why?
| Thyroid Cartilage | 1 | 2018 | 2 | 0.620 |
Why?
| Pharynx | 3 | 2014 | 31 | 0.610 |
Why?
| Vascular Neoplasms | 1 | 2018 | 17 | 0.610 |
Why?
| Mast Cells | 1 | 2018 | 54 | 0.610 |
Why?
| Endoscopy | 6 | 2015 | 119 | 0.600 |
Why?
| Postoperative Complications | 4 | 2024 | 1033 | 0.580 |
Why?
| Ki-67 Antigen | 3 | 2013 | 56 | 0.580 |
Why?
| Young Adult | 13 | 2024 | 4102 | 0.580 |
Why?
| Endovascular Procedures | 1 | 2020 | 180 | 0.580 |
Why?
| Respiratory Tract Infections | 2 | 2020 | 78 | 0.570 |
Why?
| Disease Models, Animal | 2 | 2013 | 1436 | 0.570 |
Why?
| Gene Regulatory Networks | 1 | 2018 | 106 | 0.570 |
Why?
| Deglutition | 3 | 2014 | 43 | 0.570 |
Why?
| Estradiol | 1 | 2018 | 221 | 0.560 |
Why?
| Rectum | 1 | 2017 | 52 | 0.560 |
Why?
| Eosinophilic Esophagitis | 1 | 2017 | 38 | 0.560 |
Why?
| Vagina | 1 | 2017 | 43 | 0.550 |
Why?
| Receptors, Adrenergic, beta | 1 | 2017 | 42 | 0.550 |
Why?
| Renin-Angiotensin System | 1 | 2017 | 59 | 0.550 |
Why?
| Laryngeal Neoplasms | 2 | 2015 | 43 | 0.540 |
Why?
| Ultrasonography, Prenatal | 1 | 2018 | 160 | 0.540 |
Why?
| Adult | 23 | 2024 | 13577 | 0.540 |
Why?
| Bleomycin | 3 | 2022 | 34 | 0.530 |
Why?
| Nasopharynx | 2 | 2020 | 25 | 0.530 |
Why?
| Cerebral Palsy | 2 | 2014 | 38 | 0.520 |
Why?
| Matrix Metalloproteinase 2 | 1 | 2016 | 59 | 0.510 |
Why?
| Skin Neoplasms | 2 | 2022 | 491 | 0.510 |
Why?
| Matrix Metalloproteinase 9 | 1 | 2016 | 88 | 0.510 |
Why?
| Sleep Apnea, Obstructive | 2 | 2014 | 67 | 0.500 |
Why?
| Wound Healing | 2 | 2014 | 186 | 0.500 |
Why?
| Hearing Aids | 5 | 2017 | 67 | 0.490 |
Why?
| Blood Coagulation Disorders | 3 | 2020 | 38 | 0.480 |
Why?
| Blotting, Western | 4 | 2021 | 578 | 0.470 |
Why?
| Skin Ulcer | 1 | 2014 | 9 | 0.470 |
Why?
| Alginates | 1 | 2014 | 9 | 0.470 |
Why?
| Polysaccharides | 1 | 2014 | 51 | 0.450 |
Why?
| Silver | 1 | 2014 | 48 | 0.450 |
Why?
| Adenoidectomy | 2 | 2020 | 36 | 0.450 |
Why?
| Organophosphonates | 1 | 2013 | 7 | 0.440 |
Why?
| Periodicals as Topic | 1 | 2014 | 58 | 0.440 |
Why?
| Cytosine | 1 | 2013 | 30 | 0.430 |
Why?
| RNA, Messenger | 4 | 2022 | 1089 | 0.430 |
Why?
| Signal Transduction | 3 | 2020 | 1624 | 0.430 |
Why?
| Nervous System Diseases | 1 | 2014 | 89 | 0.420 |
Why?
| Palate | 1 | 2013 | 12 | 0.420 |
Why?
| Uvula | 1 | 2013 | 13 | 0.420 |
Why?
| Pharyngeal Diseases | 1 | 2013 | 12 | 0.420 |
Why?
| Choristoma | 1 | 2013 | 24 | 0.410 |
Why?
| Infant, Premature, Diseases | 1 | 2013 | 93 | 0.410 |
Why?
| Gestational Age | 2 | 2013 | 373 | 0.410 |
Why?
| Thymus Gland | 1 | 2013 | 42 | 0.410 |
Why?
| Surgical Flaps | 2 | 2020 | 114 | 0.410 |
Why?
| Receptors, Cell Surface | 1 | 2013 | 116 | 0.400 |
Why?
| Comorbidity | 4 | 2024 | 623 | 0.400 |
Why?
| Quality of Life | 3 | 2014 | 851 | 0.400 |
Why?
| Milk Hypersensitivity | 1 | 2012 | 19 | 0.390 |
Why?
| Down Syndrome | 1 | 2013 | 90 | 0.390 |
Why?
| Sclerosing Solutions | 2 | 2022 | 15 | 0.390 |
Why?
| Pilot Projects | 4 | 2019 | 698 | 0.390 |
Why?
| Lymphangioma, Cystic | 1 | 2011 | 10 | 0.390 |
Why?
| Endothelium, Lymphatic | 1 | 2011 | 12 | 0.390 |
Why?
| Antigens, CD | 1 | 2013 | 222 | 0.380 |
Why?
| Clinical Competence | 3 | 2020 | 398 | 0.380 |
Why?
| Consensus | 4 | 2024 | 160 | 0.380 |
Why?
| Laryngeal Diseases | 2 | 2010 | 12 | 0.380 |
Why?
| Milk Proteins | 1 | 2012 | 77 | 0.380 |
Why?
| Mouth | 2 | 2010 | 32 | 0.380 |
Why?
| Microtubule-Associated Proteins | 1 | 2011 | 66 | 0.370 |
Why?
| Papillomavirus Infections | 1 | 2013 | 168 | 0.370 |
Why?
| Homeodomain Proteins | 1 | 2011 | 79 | 0.370 |
Why?
| Tracheoesophageal Fistula | 2 | 2008 | 11 | 0.370 |
Why?
| Laryngeal Mucosa | 1 | 2011 | 4 | 0.370 |
Why?
| Laryngeal Nerves | 1 | 2011 | 15 | 0.360 |
Why?
| Nervous System Physiological Phenomena | 1 | 2010 | 9 | 0.360 |
Why?
| Magnetic Resonance Angiography | 3 | 2018 | 71 | 0.360 |
Why?
| Tumor Suppressor Proteins | 1 | 2011 | 128 | 0.360 |
Why?
| Severity of Illness Index | 6 | 2014 | 978 | 0.360 |
Why?
| Osseointegration | 3 | 2017 | 32 | 0.360 |
Why?
| Neuromuscular Diseases | 1 | 2011 | 30 | 0.350 |
Why?
| Hospitals, Special | 1 | 2010 | 9 | 0.350 |
Why?
| Delphi Technique | 4 | 2024 | 55 | 0.340 |
Why?
| Airway Obstruction | 3 | 2018 | 47 | 0.340 |
Why?
| Cholesteatoma, Middle Ear | 2 | 2009 | 32 | 0.340 |
Why?
| Capillaries | 2 | 2022 | 52 | 0.340 |
Why?
| Cheek | 1 | 2010 | 9 | 0.340 |
Why?
| Lip | 1 | 2010 | 10 | 0.340 |
Why?
| Tracheal Neoplasms | 1 | 2009 | 8 | 0.330 |
Why?
| Immunohistochemistry | 4 | 2015 | 957 | 0.330 |
Why?
| Multiple Endocrine Neoplasia Type 2a | 1 | 2009 | 5 | 0.330 |
Why?
| Cicatrix | 2 | 2020 | 40 | 0.330 |
Why?
| Carcinoma, Medullary | 1 | 2009 | 12 | 0.330 |
Why?
| Proteus mirabilis | 1 | 2009 | 2 | 0.320 |
Why?
| Proteus Infections | 1 | 2009 | 4 | 0.320 |
Why?
| Bacteroidaceae Infections | 1 | 2009 | 4 | 0.320 |
Why?
| Electrocoagulation | 2 | 2009 | 12 | 0.320 |
Why?
| Bacteroides | 1 | 2009 | 14 | 0.320 |
Why?
| Brain Abscess | 1 | 2009 | 11 | 0.320 |
Why?
| Otitis Media, Suppurative | 1 | 2009 | 8 | 0.320 |
Why?
| Combined Modality Therapy | 5 | 2018 | 641 | 0.320 |
Why?
| Cerebellar Diseases | 1 | 2009 | 17 | 0.320 |
Why?
| Proto-Oncogene Proteins c-ret | 1 | 2009 | 33 | 0.320 |
Why?
| Quality Improvement | 2 | 2021 | 209 | 0.320 |
Why?
| Vomiting | 2 | 2021 | 70 | 0.310 |
Why?
| Child Development | 1 | 2010 | 192 | 0.310 |
Why?
| Real-Time Polymerase Chain Reaction | 2 | 2021 | 181 | 0.310 |
Why?
| Injections, Intralesional | 2 | 2021 | 31 | 0.300 |
Why?
| Electrosurgery | 1 | 2008 | 8 | 0.300 |
Why?
| Time Factors | 6 | 2020 | 2935 | 0.300 |
Why?
| Fibrin Tissue Adhesive | 1 | 2008 | 12 | 0.300 |
Why?
| Tracheotomy | 2 | 2019 | 14 | 0.290 |
Why?
| MicroRNAs | 2 | 2023 | 344 | 0.290 |
Why?
| Thyroid Neoplasms | 1 | 2009 | 112 | 0.290 |
Why?
| Skin, Artificial | 1 | 2007 | 10 | 0.290 |
Why?
| Hearing Loss, Unilateral | 3 | 2013 | 12 | 0.280 |
Why?
| Risk Factors | 7 | 2020 | 3724 | 0.280 |
Why?
| Fasciitis, Necrotizing | 1 | 2006 | 7 | 0.270 |
Why?
| Atlanto-Axial Joint | 1 | 2006 | 8 | 0.270 |
Why?
| Pediatrics | 3 | 2025 | 283 | 0.270 |
Why?
| Tomography, X-Ray Computed | 6 | 2015 | 1164 | 0.270 |
Why?
| Emphysema | 1 | 2006 | 15 | 0.270 |
Why?
| Diet | 1 | 2010 | 568 | 0.270 |
Why?
| Arytenoid Cartilage | 2 | 2020 | 4 | 0.260 |
Why?
| Photography | 2 | 2020 | 30 | 0.260 |
Why?
| Disease Management | 3 | 2019 | 178 | 0.260 |
Why?
| Tinnitus | 1 | 2006 | 61 | 0.260 |
Why?
| Bone Conduction | 3 | 2017 | 27 | 0.260 |
Why?
| Recurrence | 5 | 2016 | 659 | 0.250 |
Why?
| Transcranial Magnetic Stimulation | 1 | 2006 | 70 | 0.250 |
Why?
| Esophagus | 3 | 2020 | 83 | 0.250 |
Why?
| Esophagoscopy | 2 | 2020 | 27 | 0.250 |
Why?
| Radiography | 2 | 2018 | 485 | 0.240 |
Why?
| Reoperation | 5 | 2014 | 460 | 0.240 |
Why?
| Branchial Region | 1 | 2024 | 4 | 0.230 |
Why?
| Gene Expression Regulation | 2 | 2020 | 955 | 0.230 |
Why?
| Myringoplasty | 1 | 2024 | 6 | 0.230 |
Why?
| Epithelial-Mesenchymal Transition | 1 | 2024 | 51 | 0.230 |
Why?
| Tympanic Membrane Perforation | 1 | 2024 | 20 | 0.230 |
Why?
| Fellowships and Scholarships | 2 | 2016 | 120 | 0.220 |
Why?
| Cross-Sectional Studies | 3 | 2022 | 1610 | 0.220 |
Why?
| Genetic Predisposition to Disease | 3 | 2019 | 511 | 0.220 |
Why?
| Patient Selection | 2 | 2019 | 259 | 0.220 |
Why?
| Single-Blind Method | 2 | 2020 | 114 | 0.220 |
Why?
| Diagnostic Imaging | 2 | 2017 | 180 | 0.210 |
Why?
| Cohort Studies | 5 | 2020 | 1452 | 0.210 |
Why?
| Internship and Residency | 2 | 2020 | 447 | 0.210 |
Why?
| Antigens, Nuclear | 2 | 2013 | 23 | 0.210 |
Why?
| Treatment Failure | 2 | 2016 | 118 | 0.210 |
Why?
| Magnetic Resonance Imaging | 5 | 2015 | 1548 | 0.210 |
Why?
| Transplantation, Heterologous | 2 | 2013 | 75 | 0.210 |
Why?
| Mandible | 1 | 2023 | 28 | 0.200 |
Why?
| Tracheal Stenosis | 2 | 2015 | 12 | 0.200 |
Why?
| Esthetics, Dental | 1 | 2022 | 21 | 0.200 |
Why?
| Vocal Cords | 1 | 2022 | 9 | 0.200 |
Why?
| Patient Readmission | 1 | 2024 | 227 | 0.200 |
Why?
| Length of Stay | 2 | 2024 | 629 | 0.200 |
Why?
| Prognosis | 3 | 2018 | 1978 | 0.200 |
Why?
| Disease Progression | 3 | 2011 | 829 | 0.200 |
Why?
| Transforming Growth Factor beta1 | 1 | 2022 | 60 | 0.200 |
Why?
| Middle Aged | 9 | 2024 | 12611 | 0.200 |
Why?
| Mice, Nude | 2 | 2013 | 248 | 0.200 |
Why?
| Immunoenzyme Techniques | 2 | 2013 | 137 | 0.200 |
Why?
| Nevus, Blue | 1 | 2022 | 11 | 0.200 |
Why?
| Respiratory Sounds | 2 | 2019 | 48 | 0.190 |
Why?
| Databases, Factual | 1 | 2025 | 673 | 0.190 |
Why?
| Gastrointestinal Neoplasms | 1 | 2022 | 40 | 0.190 |
Why?
| Animals | 7 | 2019 | 13124 | 0.190 |
Why?
| Case-Control Studies | 2 | 2017 | 1156 | 0.190 |
Why?
| Operating Rooms | 1 | 2021 | 27 | 0.180 |
Why?
| Nausea | 1 | 2021 | 45 | 0.180 |
Why?
| Efficiency, Organizational | 1 | 2021 | 40 | 0.180 |
Why?
| Air Microbiology | 1 | 2020 | 12 | 0.180 |
Why?
| Mouth Mucosa | 1 | 2020 | 25 | 0.180 |
Why?
| Thrombelastography | 1 | 2020 | 25 | 0.180 |
Why?
| DiGeorge Syndrome | 1 | 2020 | 17 | 0.180 |
Why?
| Reference Values | 2 | 2011 | 307 | 0.170 |
Why?
| LIM Domain Proteins | 1 | 2020 | 7 | 0.170 |
Why?
| Retinal Dehydrogenase | 1 | 2020 | 10 | 0.170 |
Why?
| Myosin Type I | 1 | 2020 | 5 | 0.170 |
Why?
| Hemostasis | 1 | 2020 | 59 | 0.170 |
Why?
| Antiporters | 1 | 2020 | 19 | 0.170 |
Why?
| Dose-Response Relationship, Drug | 3 | 2013 | 1372 | 0.170 |
Why?
| Receptors, Notch | 1 | 2020 | 27 | 0.170 |
Why?
| Diagnosis, Differential | 3 | 2019 | 1033 | 0.170 |
Why?
| Hearing Loss, Conductive | 2 | 2011 | 55 | 0.170 |
Why?
| Mastoid | 3 | 2009 | 51 | 0.170 |
Why?
| Parasomnias | 1 | 2019 | 4 | 0.170 |
Why?
| Cytoskeletal Proteins | 1 | 2020 | 47 | 0.170 |
Why?
| Microsurgery | 2 | 2011 | 30 | 0.170 |
Why?
| Pain, Postoperative | 1 | 2021 | 163 | 0.170 |
Why?
| Tertiary Care Centers | 1 | 2020 | 76 | 0.170 |
Why?
| Analysis of Variance | 2 | 2014 | 552 | 0.170 |
Why?
| Physician Assistants | 1 | 2019 | 18 | 0.170 |
Why?
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2020 | 40 | 0.160 |
Why?
| Surgical Wound Infection | 1 | 2020 | 115 | 0.160 |
Why?
| Rats, Sprague-Dawley | 3 | 2009 | 1585 | 0.160 |
Why?
| Tetralogy of Fallot | 1 | 2020 | 83 | 0.160 |
Why?
| Endothelium, Vascular | 1 | 2021 | 251 | 0.160 |
Why?
| Mitochondrial Proteins | 1 | 2020 | 88 | 0.160 |
Why?
| Neovascularization, Pathologic | 1 | 2020 | 155 | 0.160 |
Why?
| Ambulatory Care | 1 | 2021 | 230 | 0.160 |
Why?
| Elastic Tissue | 1 | 2019 | 10 | 0.160 |
Why?
| Professional Role | 1 | 2019 | 77 | 0.160 |
Why?
| Microcirculation | 1 | 2019 | 72 | 0.160 |
Why?
| Nurse Practitioners | 1 | 2019 | 42 | 0.160 |
Why?
| Continuous Positive Airway Pressure | 1 | 2019 | 63 | 0.160 |
Why?
| Tryptases | 1 | 2018 | 4 | 0.160 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2020 | 198 | 0.160 |
Why?
| Sirolimus | 1 | 2019 | 62 | 0.160 |
Why?
| Age Factors | 3 | 2013 | 1110 | 0.150 |
Why?
| Dexamethasone | 1 | 2021 | 432 | 0.150 |
Why?
| p120 GTPase Activating Protein | 1 | 2018 | 1 | 0.150 |
Why?
| Fibrosis | 1 | 2019 | 181 | 0.150 |
Why?
| Heart Defects, Congenital | 1 | 2024 | 601 | 0.150 |
Why?
| Port-Wine Stain | 1 | 2018 | 14 | 0.150 |
Why?
| Estrogen Receptor beta | 1 | 2018 | 55 | 0.150 |
Why?
| Constriction, Pathologic | 1 | 2018 | 94 | 0.150 |
Why?
| Cryosurgery | 1 | 2018 | 36 | 0.150 |
Why?
| Airway Extubation | 1 | 2018 | 30 | 0.150 |
Why?
| Random Allocation | 2 | 2009 | 289 | 0.150 |
Why?
| Estrogen Receptor alpha | 1 | 2018 | 88 | 0.150 |
Why?
| Protein Transport | 1 | 2018 | 181 | 0.150 |
Why?
| Ultrasonography, Doppler | 1 | 2018 | 41 | 0.150 |
Why?
| Optical Phenomena | 1 | 2017 | 9 | 0.150 |
Why?
| Neovascularization, Physiologic | 2 | 2009 | 68 | 0.150 |
Why?
| Palatine Tonsil | 1 | 2017 | 11 | 0.140 |
Why?
| Nanomedicine | 1 | 2017 | 20 | 0.140 |
Why?
| Transcriptome | 1 | 2020 | 313 | 0.140 |
Why?
| Faculty, Medical | 2 | 2019 | 92 | 0.140 |
Why?
| Pathology, Surgical | 1 | 2017 | 17 | 0.140 |
Why?
| Constipation | 1 | 2017 | 34 | 0.140 |
Why?
| Cadaver | 1 | 2017 | 96 | 0.140 |
Why?
| Angiotensinogen | 1 | 2017 | 12 | 0.140 |
Why?
| Pressure | 1 | 2017 | 104 | 0.140 |
Why?
| Antibiotics, Antineoplastic | 1 | 2018 | 77 | 0.140 |
Why?
| Peptidyl-Dipeptidase A | 1 | 2017 | 27 | 0.140 |
Why?
| Intubation, Intratracheal | 1 | 2018 | 119 | 0.140 |
Why?
| Mice | 3 | 2013 | 5687 | 0.140 |
Why?
| Diarrhea | 1 | 2017 | 90 | 0.140 |
Why?
| Rats | 3 | 2009 | 3292 | 0.140 |
Why?
| Receptor, Angiotensin, Type 1 | 1 | 2017 | 55 | 0.140 |
Why?
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 169 | 0.140 |
Why?
| Middle Ear Ventilation | 1 | 2016 | 15 | 0.140 |
Why?
| Otitis Media with Effusion | 1 | 2016 | 15 | 0.140 |
Why?
| Child Behavior Disorders | 1 | 2017 | 74 | 0.130 |
Why?
| Mitochondria | 1 | 2020 | 399 | 0.130 |
Why?
| Child Behavior | 1 | 2017 | 106 | 0.130 |
Why?
| Food Hypersensitivity | 1 | 2017 | 98 | 0.130 |
Why?
| Serum | 1 | 2016 | 32 | 0.130 |
Why?
| Tobacco Smoke Pollution | 1 | 2016 | 48 | 0.130 |
Why?
| Drug Administration Schedule | 2 | 2013 | 370 | 0.130 |
Why?
| Hearing Loss | 1 | 2017 | 93 | 0.120 |
Why?
| Nasopharyngeal Diseases | 1 | 2015 | 4 | 0.120 |
Why?
| Anticoagulants | 1 | 2018 | 256 | 0.120 |
Why?
| Nasal Obstruction | 1 | 2015 | 12 | 0.120 |
Why?
| Urinary Bladder | 1 | 2015 | 93 | 0.120 |
Why?
| Inflammation | 1 | 2019 | 610 | 0.120 |
Why?
| Bandages, Hydrocolloid | 1 | 2014 | 4 | 0.120 |
Why?
| Gels | 1 | 2014 | 17 | 0.120 |
Why?
| North America | 1 | 2014 | 65 | 0.120 |
Why?
| Endoscopy, Digestive System | 1 | 2014 | 51 | 0.110 |
Why?
| Apoptosis | 1 | 2020 | 1097 | 0.110 |
Why?
| Biopsy, Needle | 1 | 2015 | 178 | 0.110 |
Why?
| Foreign Bodies | 2 | 2020 | 63 | 0.110 |
Why?
| Early Diagnosis | 1 | 2014 | 88 | 0.110 |
Why?
| Sickness Impact Profile | 1 | 2014 | 28 | 0.110 |
Why?
| Administration, Oral | 2 | 2018 | 434 | 0.110 |
Why?
| Term Birth | 1 | 2013 | 15 | 0.110 |
Why?
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2013 | 30 | 0.110 |
Why?
| Aged | 4 | 2022 | 9741 | 0.110 |
Why?
| Hospitals, University | 1 | 2013 | 77 | 0.100 |
Why?
| Polysomnography | 1 | 2013 | 71 | 0.100 |
Why?
| Actins | 1 | 2013 | 114 | 0.100 |
Why?
| Pregnancy | 1 | 2019 | 2452 | 0.100 |
Why?
| Otologic Surgical Procedures | 2 | 2009 | 37 | 0.100 |
Why?
| Algorithms | 1 | 2016 | 625 | 0.100 |
Why?
| Bronchoscopy | 2 | 2010 | 73 | 0.100 |
Why?
| Incidence | 2 | 2013 | 1032 | 0.100 |
Why?
| Hearing Loss, Sensorineural | 1 | 2013 | 76 | 0.100 |
Why?
| Antiviral Agents | 1 | 2013 | 170 | 0.100 |
Why?
| Lymphocele | 1 | 2011 | 7 | 0.100 |
Why?
| Tissue Survival | 1 | 2011 | 10 | 0.100 |
Why?
| Statistics, Nonparametric | 2 | 2014 | 192 | 0.100 |
Why?
| Antibodies, Monoclonal, Murine-Derived | 1 | 2011 | 45 | 0.100 |
Why?
| Tissue Culture Techniques | 1 | 2011 | 37 | 0.100 |
Why?
| Ultrasonography, Interventional | 1 | 2012 | 137 | 0.100 |
Why?
| Education, Medical, Graduate | 1 | 2014 | 217 | 0.090 |
Why?
| Internet | 1 | 2014 | 259 | 0.090 |
Why?
| Arkansas | 3 | 2016 | 1985 | 0.090 |
Why?
| Lymphocytosis | 1 | 2011 | 4 | 0.090 |
Why?
| Laryngeal Edema | 1 | 2011 | 5 | 0.090 |
Why?
| Liver | 1 | 2017 | 1132 | 0.090 |
Why?
| Brain | 1 | 2019 | 1319 | 0.090 |
Why?
| Hypertrophy | 1 | 2011 | 50 | 0.090 |
Why?
| Infant, Premature | 1 | 2013 | 317 | 0.090 |
Why?
| Nutritional Support | 1 | 2010 | 35 | 0.090 |
Why?
| Lip Neoplasms | 1 | 2010 | 3 | 0.090 |
Why?
| Auditory Threshold | 1 | 2010 | 49 | 0.080 |
Why?
| Tracheal Diseases | 1 | 2010 | 12 | 0.080 |
Why?
| United States | 5 | 2025 | 4955 | 0.080 |
Why?
| Thyroglossal Cyst | 1 | 2009 | 4 | 0.080 |
Why?
| Hospitals, Teaching | 1 | 2010 | 54 | 0.080 |
Why?
| Tongue Diseases | 1 | 2009 | 7 | 0.080 |
Why?
| Medical Records | 1 | 2010 | 85 | 0.080 |
Why?
| Vincristine | 1 | 2009 | 82 | 0.080 |
Why?
| Calcitonin | 1 | 2009 | 30 | 0.080 |
Why?
| Blood Flow Velocity | 2 | 2020 | 99 | 0.080 |
Why?
| Sensory Thresholds | 1 | 2009 | 18 | 0.080 |
Why?
| Granulation Tissue | 1 | 2009 | 9 | 0.080 |
Why?
| Antineoplastic Agents, Phytogenic | 1 | 2009 | 66 | 0.080 |
Why?
| Rhinitis | 1 | 2009 | 26 | 0.080 |
Why?
| Lymphotoxin-alpha | 1 | 2009 | 8 | 0.080 |
Why?
| Tympanic Membrane | 1 | 2009 | 37 | 0.080 |
Why?
| Societies, Medical | 2 | 2025 | 187 | 0.080 |
Why?
| Neoplasm Invasiveness | 1 | 2010 | 269 | 0.080 |
Why?
| Physical Examination | 1 | 2009 | 93 | 0.080 |
Why?
| Mucous Membrane | 1 | 2009 | 28 | 0.080 |
Why?
| Sinusitis | 1 | 2009 | 41 | 0.080 |
Why?
| Turner Syndrome | 1 | 2008 | 15 | 0.080 |
Why?
| Thyroidectomy | 1 | 2009 | 60 | 0.080 |
Why?
| Biopsy, Fine-Needle | 1 | 2009 | 108 | 0.080 |
Why?
| Infusions, Intravenous | 1 | 2009 | 213 | 0.080 |
Why?
| Transplantation, Homologous | 1 | 2009 | 145 | 0.080 |
Why?
| Ear Diseases | 1 | 2008 | 27 | 0.080 |
Why?
| Burns, Electric | 1 | 2008 | 2 | 0.080 |
Why?
| Chi-Square Distribution | 1 | 2009 | 277 | 0.080 |
Why?
| Fires | 1 | 2008 | 14 | 0.080 |
Why?
| Suction | 1 | 2008 | 23 | 0.070 |
Why?
| Shock, Septic | 1 | 2009 | 79 | 0.070 |
Why?
| Sleep Apnea Syndromes | 1 | 2008 | 30 | 0.070 |
Why?
| Photomicrography | 1 | 2007 | 7 | 0.070 |
Why?
| Factor VII | 1 | 2007 | 3 | 0.070 |
Why?
| Hospitals, Pediatric | 2 | 2019 | 235 | 0.070 |
Why?
| Mouth Floor | 1 | 2007 | 5 | 0.070 |
Why?
| Neoplasm Staging | 1 | 2010 | 746 | 0.070 |
Why?
| Polyvinyl Alcohol | 1 | 2007 | 9 | 0.070 |
Why?
| Postoperative Care | 1 | 2008 | 104 | 0.070 |
Why?
| Collateral Circulation | 1 | 2007 | 39 | 0.070 |
Why?
| Biocompatible Materials | 1 | 2007 | 66 | 0.070 |
Why?
| Intraoperative Complications | 1 | 2008 | 114 | 0.070 |
Why?
| Auditory Cortex | 1 | 2006 | 20 | 0.070 |
Why?
| Patient Satisfaction | 1 | 2008 | 278 | 0.070 |
Why?
| Angiography | 1 | 2007 | 128 | 0.070 |
Why?
| Therapy, Computer-Assisted | 1 | 2006 | 31 | 0.070 |
Why?
| Thalamus | 1 | 2006 | 38 | 0.070 |
Why?
| Arousal | 1 | 2006 | 98 | 0.070 |
Why?
| Phenotype | 2 | 2019 | 739 | 0.060 |
Why?
| Swine | 1 | 2007 | 408 | 0.060 |
Why?
| Psychomotor Performance | 1 | 2006 | 130 | 0.060 |
Why?
| Reaction Time | 1 | 2006 | 214 | 0.060 |
Why?
| Attention | 1 | 2006 | 172 | 0.060 |
Why?
| Preoperative Care | 1 | 2007 | 169 | 0.060 |
Why?
| Radiopharmaceuticals | 1 | 2006 | 204 | 0.060 |
Why?
| Fluorodeoxyglucose F18 | 1 | 2006 | 189 | 0.060 |
Why?
| Chronic Disease | 3 | 2016 | 573 | 0.060 |
Why?
| Emergency Service, Hospital | 1 | 2009 | 484 | 0.060 |
Why?
| Advisory Committees | 1 | 2025 | 65 | 0.060 |
Why?
| Positron-Emission Tomography | 1 | 2006 | 292 | 0.060 |
Why?
| Craniofacial Abnormalities | 1 | 2024 | 27 | 0.060 |
Why?
| Human Umbilical Vein Endothelial Cells | 1 | 2024 | 90 | 0.060 |
Why?
| Mice, Inbred C57BL | 1 | 2009 | 1808 | 0.050 |
Why?
| Anti-Bacterial Agents | 1 | 2009 | 745 | 0.050 |
Why?
| Mutation | 2 | 2019 | 1280 | 0.050 |
Why?
| Otitis Media | 2 | 2016 | 28 | 0.050 |
Why?
| Growth Differentiation Factor 2 | 1 | 2022 | 6 | 0.050 |
Why?
| Apoptosis Regulatory Proteins | 1 | 2023 | 82 | 0.050 |
Why?
| Transforming Growth Factor beta | 1 | 2022 | 136 | 0.050 |
Why?
| Registries | 1 | 2025 | 563 | 0.050 |
Why?
| Gastrointestinal Hemorrhage | 1 | 2022 | 80 | 0.050 |
Why?
| Esophagoscopes | 1 | 2020 | 1 | 0.050 |
Why?
| Blood Coagulation Tests | 1 | 2020 | 20 | 0.040 |
Why?
| Blood Coagulation | 1 | 2020 | 60 | 0.040 |
Why?
| Fetus | 1 | 2021 | 183 | 0.040 |
Why?
| Gastrostomy | 1 | 2020 | 56 | 0.040 |
Why?
| Ligands | 1 | 2020 | 203 | 0.040 |
Why?
| Exhalation | 1 | 2019 | 20 | 0.040 |
Why?
| Embryonic Development | 1 | 2019 | 16 | 0.040 |
Why?
| Genetic Loci | 1 | 2019 | 45 | 0.040 |
Why?
| Risk | 1 | 2020 | 324 | 0.040 |
Why?
| Disease Susceptibility | 1 | 2019 | 88 | 0.040 |
Why?
| Income | 1 | 2019 | 104 | 0.040 |
Why?
| Angiogenesis Inhibitors | 1 | 2020 | 183 | 0.040 |
Why?
| Genetic Association Studies | 1 | 2019 | 119 | 0.040 |
Why?
| Syndrome | 1 | 2019 | 240 | 0.040 |
Why?
| Hemorrhage | 1 | 2020 | 197 | 0.040 |
Why?
| Double-Blind Method | 1 | 2020 | 708 | 0.040 |
Why?
| Gene Expression | 1 | 2021 | 610 | 0.040 |
Why?
| Comparative Genomic Hybridization | 1 | 2018 | 43 | 0.040 |
Why?
| Fibrin Fibrinogen Degradation Products | 1 | 2018 | 10 | 0.040 |
Why?
| Fibrinogen | 1 | 2018 | 32 | 0.040 |
Why?
| Tertiary Healthcare | 1 | 2017 | 15 | 0.040 |
Why?
| DNA-Binding Proteins | 1 | 2020 | 418 | 0.040 |
Why?
| Transcription Factors | 1 | 2020 | 565 | 0.030 |
Why?
| Cost-Benefit Analysis | 1 | 2017 | 266 | 0.030 |
Why?
| Triage | 1 | 2016 | 60 | 0.030 |
Why?
| Pain | 1 | 2018 | 387 | 0.030 |
Why?
| Multivariate Analysis | 1 | 2016 | 583 | 0.030 |
Why?
| Odds Ratio | 1 | 2016 | 551 | 0.030 |
Why?
| Quality-Adjusted Life Years | 1 | 2015 | 63 | 0.030 |
Why?
| Patient-Centered Care | 1 | 2016 | 130 | 0.030 |
Why?
| Job Application | 1 | 2014 | 12 | 0.030 |
Why?
| Personnel Selection | 1 | 2014 | 24 | 0.030 |
Why?
| Logistic Models | 1 | 2016 | 900 | 0.030 |
Why?
| Personal Satisfaction | 1 | 2014 | 78 | 0.030 |
Why?
| Patient Care Team | 1 | 2015 | 258 | 0.030 |
Why?
| Temporal Bone | 1 | 2013 | 36 | 0.030 |
Why?
| Practice Guidelines as Topic | 1 | 2016 | 468 | 0.030 |
Why?
| Patient Admission | 1 | 2013 | 76 | 0.030 |
Why?
| Oximetry | 1 | 2013 | 68 | 0.020 |
Why?
| Program Evaluation | 1 | 2014 | 349 | 0.020 |
Why?
| Decision Making | 1 | 2014 | 272 | 0.020 |
Why?
| Electrocardiography | 1 | 2013 | 266 | 0.020 |
Why?
| Referral and Consultation | 1 | 2013 | 288 | 0.020 |
Why?
| Blood Pressure | 1 | 2013 | 531 | 0.020 |
Why?
| Blood Glucose | 1 | 2013 | 446 | 0.020 |
Why?
| Suture Anchors | 1 | 2010 | 11 | 0.020 |
Why?
| Fiber Optic Technology | 1 | 2010 | 16 | 0.020 |
Why?
| Safety | 1 | 2010 | 77 | 0.020 |
Why?
| Prolapse | 1 | 2009 | 6 | 0.020 |
Why?
| Equipment Design | 1 | 2010 | 289 | 0.020 |
Why?
| Ear, Middle | 1 | 2008 | 19 | 0.020 |
Why?
| Demography | 1 | 2009 | 94 | 0.020 |
Why?
| Electric Power Supplies | 1 | 2008 | 1 | 0.020 |
Why?
| Acute Disease | 1 | 2009 | 373 | 0.020 |
Why?
| Drainage | 1 | 2008 | 79 | 0.020 |
Why?
| Aged, 80 and over | 1 | 2015 | 3226 | 0.020 |
Why?
| Factor VIIa | 1 | 2007 | 9 | 0.020 |
Why?
| Postoperative Hemorrhage | 1 | 2007 | 52 | 0.020 |
Why?
| Survival Rate | 1 | 2008 | 909 | 0.020 |
Why?
| Recombinant Proteins | 1 | 2007 | 476 | 0.020 |
Why?
|
|
Richter's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|